- IXRS® 2.0
- ePRO
- Statistical Services
- Web Drug Reconciliation
- Clinical Helpline
- Almac Interactive Reporting
- Experience
- Project Management
- Quality
- The Patient Journey
- Technical Support
Keyword
Adaptive Trial Design
Almac’s suite of technologies and biostatistical services seamlessly implement and support adaptive trial design. Well-designed adaptive trials result in lower drug development costs, reduced time to market, faster go-no-go-decisions, and improved patient safety.
Our IXRS® and ePRO tools capture safety and efficacy data and make it viewable in real-time, so that sponsors have the information to take action as predetermined in the protocol. The flexibility of IXRS® facilitates making changes (e.g., dropping or adding treatment arms, changing doses,) during the course of a trial.
Almac has experience in implementing over 100 adaptive studies and has established the reputation as a market leader in the area.
